Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Washington Capitals Star Alex Ovechkin Announces "THE GR8 CHASE for Victory Over Cancer®" Amidst Historic Chase for NHL Goal-Scoring Record


News provided by

V Foundation for Cancer Research

Mar 05, 2025, 09:02 ET

Share this article

Share toX

Share this article

Share toX

Ovechkin, the Washington Capitals, Hockey Fights Cancer™ and the V Foundation for Cancer Research are Partnering to Raise Funds for Pediatric Cancer Research

WASHINGTON, March 5, 2025 /PRNewswire/ -- Washington Capitals star forward Alex Ovechkin is teaming up with the Capitals, Hockey Fights Cancer™ and the V Foundation for Cancer Research to launch THE GR8 CHASE for Victory Over Cancer®, an initiative to raise awareness and funds for pediatric cancer research as he nears the National Hockey League's all-time career goals record. 100% of donations to the cause will go directly toward pediatric cancer research through the V Foundation, and donations can be made at v.org/GR8chase.

Continue Reading

Alex Ovechkin Announces "THE GR8 CHASE for Victory Over Cancer®

Post this
Washington Capitals Star Alex Ovechkin Announces “THE GR8 CHASE for Victory Over Cancer®” Amidst Historic Chase for NHL Goal-Scoring Record
Washington Capitals Star Alex Ovechkin Announces “THE GR8 CHASE for Victory Over Cancer®” Amidst Historic Chase for NHL Goal-Scoring Record
Alex Ovechkin, the Washington Capitals, Hockey Fights Cancer™ and the V Foundation for Cancer Research are Partnering to Raise Funds for Pediatric Cancer Research
Alex Ovechkin, the Washington Capitals, Hockey Fights Cancer™ and the V Foundation for Cancer Research are Partnering to Raise Funds for Pediatric Cancer Research
THE GR8 CHASE for Victory Over Cancer®
THE GR8 CHASE for Victory Over Cancer®

As part of THE GR8 CHASE for Victory Over Cancer® campaign, Ovechkin will donate an amount equal to his career goal total for every goal he scores during the remainder of his NHL career, starting with Wednesday's Capitals game against the New York Rangers. Ovechkin's donations will be matched by Monumental Sports & Entertainment, meaning each goal scored will bring a donation that is double his career goal total at that time. Ovechkin is inviting fans to make an impact alongside him. Fans can support THE GR8 CHASE by donating $8, or any amount they can give, in honor of his historic pursuit of the NHL's all-time goals record.

In his 20th season, Ovechkin is rapidly closing in on the NHL's all-time career goals record. The pursuit, dubbed THE GR8 CHASE based on Alex Ovechkin's jersey number of 8, is heating up, with Ovechkin only 10 goals away from the current record of 894 goals held by Wayne Gretzky. While creating a historic legacy on the ice, Ovechkin is also dedicated to leaving a lasting impact off the ice.

"I'm proud to join the V Foundation and support their efforts to fund lifesaving cancer research," said Ovechkin. "Throughout my NHL career, I have met many brave kids battling cancer, and I feel it's important to do what I can to help save more lives from this horrible disease. I want to thank the V Foundation for all their hard work, and I look forward to using my platform and doing anything I can to help further the V Foundation and Hockey Fights Cancer's mission."

Donations raised by the campaign will go to the V Foundation through Hockey Fights Cancer and support the Alex Ovechkin GR8 CHASE Pediatric Cancer Research Grant. Cancer is the leading cause of disease-related death among children and adolescents, but survival rates are improving because of research. Today, 85% of kids with cancer survive five years or more, up from 58% in the 1970s. Since its inception, the V Foundation has awarded over $91 million in pediatric cancer research grants, funding 241 grants across North America.

"This is a true power play," said Shane Jacobson, CEO of the V Foundation for Cancer Research. "Alex Ovechkin's summit to greatness on the ice has been a thrill for all hockey fans, and his commitment to funding innovative pediatric cancer research will make a lifesaving impact for years to come. We are thrilled to have Alex on our team. We look forward to celebrating his accomplishments and celebrating advancements in cancer research together as we accelerate Victory Over Cancer®."

The Capitals and Ovechkin have a long-standing history of supporting Hockey Fights Cancer. The Capitals host a Hockey Fights Cancer Night each season to raise awareness and funds toward cancer research. Through the Capitals' charitable arm, Monumental Sports & Entertainment Foundation, the organization contributes funds to cancer-related charities annually. The Capitals also frequently host events and support initiatives with community partners and individuals in the cancer community, including a Hockey Fights Cancer skate with youth impacted by the disease. To learn more, visit WashCaps.com/CapsFightCancer.

THE GR8 CHASE for Victory Over Cancer® is one of several community initiatives supported by Ovechkin. Ovechkin launched Ovi's 8's in 2006 to provide underserved children with tickets to a Capitals game. Since then, more than 6,000 individuals have had a chance to see a game free of charge. In addition, Ovechkin has a long-standing relationship with the American Special Hockey Association (ASHA), having hosted multiple ASHA skating sessions as well as a street hockey event since 2014. Ovechkin also supports organizations that facilitate the wishes of sick children, having granted several wishes during his career with the Capitals.

The V Foundation for Cancer Research is the official charitable partner of Hockey Fights Cancer™, raising funds and awareness for all types of cancer research. Over the course of the 2023-2024 season, the first year of partnership, Hockey Fights Cancer™ raised over $4 million, with $2.9 million going to groundbreaking cancer research through the V Foundation.

About the V Foundation for Cancer Research
The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach, ESPN commentator and member of the Naismith Memorial Basketball Hall of Fame. The V Foundation has funded nearly $400 million in game-changing cancer research grants in North America through a competitive process strictly supervised by a world-class Scientific Advisory Committee. Because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations is awarded to cancer research and programs. The V team is committed to funding the best scientists to accelerate Victory Over Cancer® and save lives. To learn more, visit v.org.

About Hockey Fights Cancer™
Founded in 1998 by the NHL and NHLPA, the first national cause program pioneered by a major sports league, the Hockey Fights Cancer initiative powered by the V Foundation presented by AstraZeneca has raised more than $36 million since its inception. Last season, Hockey Fights Cancer celebrated its 25th anniversary by setting a fundraising record of over $4 million in its first season as Hockey Fights Cancer powered by the V Foundation for Cancer Research. From that total, $2.9 million was raised with the V Foundation and will go directly to lifesaving cancer research through 10 research grants to the best and brightest scientists across the U.S. and Canada. As part of that $4 million+ raised, $1.2 million was raised by Clubs for local cancer-related organizations and charities in the Clubs' communities.

SOURCE V Foundation for Cancer Research

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Game-Changing Collaboration Will Accelerate Cancer Vaccines

The V Foundation for Cancer Research, a top-rated cancer charity, announced an exciting partnership with Cancer Vaccine Coalition (CVC), a...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

General Sports

General Sports

Sporting Events

Sporting Events

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.